Header Logo

Connection

Julie Schneider to Cognitive Dysfunction

Back to Details
This is a "connection" page, showing publications Julie Schneider has written about Cognitive Dysfunction.
Julie Schneider
Connection Strength
10.089
Cognitive Dysfunction
  1. Cerebral Small Vessel Disease, Hypertension, and Vascular Contributions to Cognitive Impairment and Dementia. Hypertension. 2024 Jan; 81(1):75-86.
    View in: PubMed
    Score: 0.482
  2. Association of Mediterranean-DASH Intervention for Neurodegenerative Delay and Mediterranean Diets With Alzheimer Disease Pathology. Neurology. 2023 05 30; 100(22):e2259-e2268.
    View in: PubMed
    Score: 0.458
  3. Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based study. Mol Psychiatry. 2022 10; 27(10):4307-4313.
    View in: PubMed
    Score: 0.445
  4. Complex Profiles of Cerebrovascular Disease Pathologies in the Aging Brain and Their Relationship With Cognitive Decline. Stroke. 2022 01; 53(1):218-227.
    View in: PubMed
    Score: 0.415
  5. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents. Neurology. 2020 10 13; 95(15):e2056-e2064.
    View in: PubMed
    Score: 0.383
  6. Limbic-predominant age-related TDP-43 encephalopathy, ADNC pathology, and cognitive decline in aging. Neurology. 2020 10 06; 95(14):e1951-e1962.
    View in: PubMed
    Score: 0.383
  7. Hospitalization, Alzheimer's Disease and Related Neuropathologies, and Cognitive Decline. Ann Neurol. 2019 12; 86(6):844-852.
    View in: PubMed
    Score: 0.362
  8. Cognitive decline after elective and nonelective hospitalizations in older adults. Neurology. 2019 02 12; 92(7):e690-e699.
    View in: PubMed
    Score: 0.343
  9. GSK3? Interactions with Amyloid Genes: An Autopsy Verification and Extension. Neurotox Res. 2015 Oct; 28(3):232-8.
    View in: PubMed
    Score: 0.270
  10. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann Neurol. 2015 Jun; 77(6):942-52.
    View in: PubMed
    Score: 0.265
  11. Selective serotonin reuptake inhibitor use, age-related neuropathology and cognition in late-life. Psychiatry Res. 2023 10; 328:115471.
    View in: PubMed
    Score: 0.119
  12. Age-related and amyloid-beta-independent tau deposition and its downstream effects. Brain. 2023 08 01; 146(8):3192-3205.
    View in: PubMed
    Score: 0.118
  13. Associations of VGF with Neuropathologies and Cognitive Health in Older Adults. Ann Neurol. 2023 08; 94(2):232-244.
    View in: PubMed
    Score: 0.116
  14. Neuropathologic correlates of cerebral microbleeds in community-based older adults. Neurobiol Aging. 2023 09; 129:89-98.
    View in: PubMed
    Score: 0.116
  15. Sex differences in associations between APOE e2 and longitudinal cognitive decline. Alzheimers Dement. 2023 10; 19(10):4651-4661.
    View in: PubMed
    Score: 0.115
  16. The association of MIND diet with cognitive resilience to neuropathologies. Alzheimers Dement. 2023 08; 19(8):3644-3653.
    View in: PubMed
    Score: 0.114
  17. Brain ?-Amyloid Links the Association of Change in Body Mass Index With Cognitive Decline in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2023 02 24; 78(2):277-285.
    View in: PubMed
    Score: 0.114
  18. Estrogen Receptor Genes, Cognitive Decline, and Alzheimer Disease. Neurology. 2023 04 04; 100(14):e1474-e1487.
    View in: PubMed
    Score: 0.114
  19. Multi-Site Cross-Site Inter-Rater and Test-Retest Reliability and Construct Validity of the MarkVCID White Matter Hyperintensity Growth and Regression Protocol. J Alzheimers Dis. 2023; 96(2):683-693.
    View in: PubMed
    Score: 0.113
  20. Brain vitamin D forms, cognitive decline, and neuropathology in community-dwelling older adults. Alzheimers Dement. 2023 06; 19(6):2389-2396.
    View in: PubMed
    Score: 0.113
  21. Frequency and Underlying Pathology of Pure Vascular Cognitive Impairment. JAMA Neurol. 2022 12 01; 79(12):1277-1286.
    View in: PubMed
    Score: 0.112
  22. Association of Dietary Intake of Flavonols With Changes in Global Cognition and Several Cognitive Abilities. Neurology. 2023 02 14; 100(7):e694-e702.
    View in: PubMed
    Score: 0.112
  23. Co-expression network analysis of frontal cortex during the progression of Alzheimer's disease. Cereb Cortex. 2022 11 09; 32(22):5108-5120.
    View in: PubMed
    Score: 0.112
  24. Longitudinal change in serial position scores in older adults with entorhinal and hippocampal neuropathologies. J Int Neuropsychol Soc. 2023 Jul; 29(6):561-571.
    View in: PubMed
    Score: 0.111
  25. Cerebral amyloid angiopathy interacts with neuritic amyloid plaques to promote tau and cognitive decline. Brain. 2022 08 27; 145(8):2823-2833.
    View in: PubMed
    Score: 0.110
  26. Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease. Brain. 2022 07 29; 145(7):2541-2554.
    View in: PubMed
    Score: 0.110
  27. RNASE6 is a novel modifier of APOE-e4 effects on cognition. Neurobiol Aging. 2022 10; 118:66-76.
    View in: PubMed
    Score: 0.109
  28. Limbic-predominant age-related TDP-43 encephalopathy neuropathological change (LATE-NC) is associated with lower R2 relaxation rate: an ex-vivo MRI and pathology investigation. Neurobiol Aging. 2022 09; 117:128-138.
    View in: PubMed
    Score: 0.108
  29. Caffeine Consumption and Dementia: Are Lewy Bodies the Link? Ann Neurol. 2022 06; 91(6):834-846.
    View in: PubMed
    Score: 0.107
  30. Cortical Proteins and Individual Differences in Cognitive Resilience in Older Adults. Neurology. 2022 03 29; 98(13):e1304-e1314.
    View in: PubMed
    Score: 0.107
  31. Neuropathology of Vascular Brain Health: Insights From Ex Vivo Magnetic Resonance Imaging-Histopathology Studies in Cerebral Small Vessel Disease. Stroke. 2022 02; 53(2):404-415.
    View in: PubMed
    Score: 0.106
  32. Genetic Evidence Supporting a Causal Role of Depression in Alzheimer's Disease. Biol Psychiatry. 2022 07 01; 92(1):25-33.
    View in: PubMed
    Score: 0.105
  33. The association of Lewy bodies with limbic-predominant age-related TDP-43 encephalopathy neuropathologic changes and their role in cognition and Alzheimer's dementia in older persons. Acta Neuropathol Commun. 2021 09 25; 9(1):156.
    View in: PubMed
    Score: 0.104
  34. To what degree is late life cognitive decline driven by age-related neuropathologies? Brain. 2021 08 17; 144(7):2166-2175.
    View in: PubMed
    Score: 0.103
  35. The "cognitive clock": A novel indicator of brain health. Alzheimers Dement. 2021 12; 17(12):1923-1937.
    View in: PubMed
    Score: 0.101
  36. PLD3 is a neuronal lysosomal phospholipase D associated with ?-amyloid plaques and cognitive function in Alzheimer's disease. PLoS Genet. 2021 04; 17(4):e1009406.
    View in: PubMed
    Score: 0.100
  37. A cortical immune network map identifies distinct microglial transcriptional programs associated with ?-amyloid and Tau pathologies. Transl Psychiatry. 2021 01 14; 11(1):50.
    View in: PubMed
    Score: 0.099
  38. Association of serial position scores on memory tests and hippocampal-related neuropathologic outcomes. Neurology. 2020 12 15; 95(24):e3303-e3312.
    View in: PubMed
    Score: 0.097
  39. Cortical Proteins Associated With Cognitive Resilience in Community-Dwelling Older Persons. JAMA Psychiatry. 2020 11 01; 77(11):1172-1180.
    View in: PubMed
    Score: 0.097
  40. Association of Early-Life Cognitive Enrichment With Alzheimer Disease Pathological Changes and Cognitive Decline. JAMA Neurol. 2020 10 01; 77(10):1217-1224.
    View in: PubMed
    Score: 0.097
  41. Cross-Species Analyses Identify Dlgap2 as a Regulator of Age-Related Cognitive Decline and Alzheimer's Dementia. Cell Rep. 2020 09 01; 32(9):108091.
    View in: PubMed
    Score: 0.096
  42. Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults. Stroke. 2020 09; 51(9):2825-2833.
    View in: PubMed
    Score: 0.096
  43. Genetic variants and functional pathways associated with resilience to Alzheimer's disease. Brain. 2020 08 01; 143(8):2561-2575.
    View in: PubMed
    Score: 0.096
  44. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults. J Alzheimers Dis. 2020; 73(1):333-345.
    View in: PubMed
    Score: 0.092
  45. Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices. Alzheimers Dement. 2020 01; 16(1):209-218.
    View in: PubMed
    Score: 0.092
  46. Sleep fragmentation, microglial aging, and cognitive impairment in adults with and without Alzheimer's dementia. Sci Adv. 2019 12; 5(12):eaax7331.
    View in: PubMed
    Score: 0.091
  47. APOE e4-specific associations of VEGF gene family expression with cognitive aging and Alzheimer's disease. Neurobiol Aging. 2020 03; 87:18-25.
    View in: PubMed
    Score: 0.091
  48. Association of TDP-43 Pathology With Domain-specific Literacy in Older Persons. Alzheimer Dis Assoc Disord. 2019 Oct-Dec; 33(4):315-320.
    View in: PubMed
    Score: 0.090
  49. The synaptic pathology of cognitive life?. Dialogues Clin Neurosci. 2019 09; 21(3):271-279.
    View in: PubMed
    Score: 0.090
  50. Microstructural changes in the brain mediate the association of AK4, IGFBP5, HSPB2, and ITPK1 with cognitive decline. Neurobiol Aging. 2019 12; 84:17-25.
    View in: PubMed
    Score: 0.089
  51. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer's disease. Mol Psychiatry. 2021 03; 26(3):888-896.
    View in: PubMed
    Score: 0.089
  52. Vascular Cognitive Impairment and?Dementia: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019 07 02; 73(25):3326-3344.
    View in: PubMed
    Score: 0.089
  53. Association of Cortical ?-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease. JAMA Neurol. 2019 07 01; 76(7):818-826.
    View in: PubMed
    Score: 0.089
  54. Antiphospholipid Antibodies: Cognitive and Motor Decline, Neuroimaging and Neuropathology. Neuroepidemiology. 2019; 53(1-2):100-107.
    View in: PubMed
    Score: 0.088
  55. Scam Awareness Related to Incident Alzheimer Dementia and Mild Cognitive Impairment: A Prospective Cohort Study. Ann Intern Med. 2019 05 21; 170(10):702-709.
    View in: PubMed
    Score: 0.087
  56. Risk Aversion and Alzheimer Disease in Old Age. Am J Geriatr Psychiatry. 2019 08; 27(8):851-861.
    View in: PubMed
    Score: 0.087
  57. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry. 2020 11; 25(11):2932-2941.
    View in: PubMed
    Score: 0.086
  58. Postmortem neurodegenerative markers and trajectories of decline in cognitive systems. Neurology. 2019 02 19; 92(8):e831-e840.
    View in: PubMed
    Score: 0.086
  59. Neurofibrillary Tangles and Conversion to Mild Cognitive Impairment with Certain Antihypertensives. J Alzheimers Dis. 2019; 70(1):153-161.
    View in: PubMed
    Score: 0.086
  60. Polygenic analysis of inflammatory disease variants and effects on microglia in the aging brain. Mol Neurodegener. 2018 07 24; 13(1):38.
    View in: PubMed
    Score: 0.083
  61. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer's disease. Nat Neurosci. 2018 06; 21(6):811-819.
    View in: PubMed
    Score: 0.082
  62. Postmortem brain MRI is related to cognitive decline, independent of cerebral vessel disease in older adults. Neurobiol Aging. 2018 09; 69:177-184.
    View in: PubMed
    Score: 0.082
  63. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 06 12; 90(24):e2127-e2134.
    View in: PubMed
    Score: 0.082
  64. Frontotemporal dysregulation of the SNARE protein interactome is associated with faster cognitive decline in old age. Neurobiol Dis. 2018 06; 114:31-44.
    View in: PubMed
    Score: 0.081
  65. Vascular cognitive impairment. Nat Rev Dis Primers. 2018 02 15; 4:18003.
    View in: PubMed
    Score: 0.081
  66. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018 01; 83(1):74-83.
    View in: PubMed
    Score: 0.080
  67. Association Between Brain Gene Expression, DNA Methylation, and Alteration of Ex Vivo Magnetic Resonance Imaging Transverse Relaxation in Late-Life Cognitive Decline. JAMA Neurol. 2017 12 01; 74(12):1473-1480.
    View in: PubMed
    Score: 0.079
  68. Outcomes after diagnosis of mild cognitive impairment in a large autopsy series. Ann Neurol. 2017 Apr; 81(4):549-559.
    View in: PubMed
    Score: 0.076
  69. Decreased cortical FADD protein is associated with clinical dementia and cognitive decline in an elderly community sample. Mol Neurodegener. 2017 03 20; 12(1):26.
    View in: PubMed
    Score: 0.076
  70. Role of APOE e4 Allele and Incident Stroke on Cognitive Decline and Mortality. Alzheimer Dis Assoc Disord. 2016 Oct-Dec; 30(4):318-323.
    View in: PubMed
    Score: 0.073
  71. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline. Neurobiol Aging. 2016 09; 45:169-177.
    View in: PubMed
    Score: 0.072
  72. Temporal course of neurodegenerative effects on cognition in old age. Neuropsychology. 2016 07; 30(5):591-9.
    View in: PubMed
    Score: 0.071
  73. Interaction of transactive response DNA binding protein 43 with nuclear factor ?B in mild cognitive impairment with episodic memory deficits. Acta Neuropathol Commun. 2014 Apr 01; 2:37.
    View in: PubMed
    Score: 0.062
  74. Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
    View in: PubMed
    Score: 0.055
  75. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis. 2012; 29(3):691-7.
    View in: PubMed
    Score: 0.053
  76. Alzheimer's disease frequency peaks in the tenth decade and is lower afterwards. Acta Neuropathol Commun. 2019 07 03; 7(1):104.
    View in: PubMed
    Score: 0.022
  77. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019 01 24; 10(1):409.
    View in: PubMed
    Score: 0.022
  78. Neurodegenerative disease and cognitive retest learning. Neurobiol Aging. 2018 06; 66:122-130.
    View in: PubMed
    Score: 0.020
  79. Genetic influence of plasma homocysteine on Alzheimer's disease. Neurobiol Aging. 2018 02; 62:243.e7-243.e14.
    View in: PubMed
    Score: 0.020
  80. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia. Behav Brain Res. 2017 03 30; 322(Pt B):233-240.
    View in: PubMed
    Score: 0.018
  81. CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology. Nat Neurosci. 2013 Jul; 16(7):848-50.
    View in: PubMed
    Score: 0.015
  82. Neuropathologic correlates of hippocampal atrophy in the elderly: a clinical, pathologic, postmortem MRI study. PLoS One. 2011; 6(10):e26286.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.